646-34-4

Usage

InChI:InChI=1/CH5N3.H2O4S/c2-1(3)4;1-5(2,3)4/h(H5,2,3,4);(H2,1,2,3,4)

Upstream product

• 867-44-7 S-Methylisothiourea sulfate 

Downstream Products

• 5587-93-9 2,5,7-Triamino-4-phenylpyrimido<4,5-d>pyrimidine 
• 685897-68-1 2-amino-4,6-dimethyl-5-pyrimidinol 
• 1060548-70-0 2-amino-4-(2-hydroxyphenyl)-6-[2-(2-pyridyl)vinyl]-1,3,5-triazine 
• 1060548-75-5 2-amino-4-(2-hydroxyphenyl)-6-[2-(4-chlorophenyl)vinyl]-1,3,5-triazine 
• 1060548-79-9 2-amino-4-(2-hydroxyphenyl)-6-[2-(4-dimethylaminophenyl)vinyl]-1,3,5-triazine 
• 1060548-82-4 2-amino-4-(2-hydroxyphenyl)-6-[2-(4-methylthiophenyl)vinyl]-1,3,5-triazine 
• 1060548-85-7 2-amino-4-(2-hydroxyphenyl)-6-[2-(1-methylindol-3-yl)vinyl]-1,3,5-triazine 
• 1060548-87-9 2-amino-4-(2-hydroxyphenyl)-6-[2-(thienyl)vinyl]-1,3,5-triazine 
• 1054606-09-5 C₂₅H₂₉N₃O₃ 
• 97-39-2 1,3-Di(2-tolyl)guanidine 
• 1251919-85-3 2-amino-4-[4-(pyrrol-1-yl)phenyl]-6-(2-thienyl)pyrimidine 
• 1251919-89-7 2-amino-4-(4-aminophenyl)-6-(3,4-ethylenedioxythien-2-yl)pyrimidine 

Relevant academic research and scientific papers

PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS

The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.

Water-soluble derivatives of camptothecin/homocamptothecin

Camptothecin and homocamptothecin analogs and derivatives are provided incorporating alkylamine and polyalkylamine moieties.

Heterocyclic amidino substituted ureas and their pharmaceutical uses

This invention relates to methods for the prophylactic and curative treatment of gastrointestinal and cardiovascular disorders and parasitic infections in humans and animals, using a class of hetrocyclic amidino substituted urea and thiourea compounds, a novel class of heterocyclic amidino substituted urea and thiourea compounds and pharmaceutical compositions and animal feed additives including the same.

Imaging agent and method of use

A new radiopharmaceutical composition for use in nuclear medicine comprises a radioiodinated meta-iodobenzylguanidine. The composition is used as an imaging agent for the heart, adrenal medulla, and tumors of the adrenal medulla and can be used for treatm

Process for preparing guanidine

A process is described for preparing guanidine by separating guanidine from a process stream obtained in a urea synthesis process, wherein ammonia and carbon dioxide are reacted at a high temperature and a high pressure. The process stream includes a urea synthesis effluent from a urea synthesis zone, a solution obtained by separating unreacted materials from the effluent, a concentrate of the solution or a mother liquor derived from a urea crystallization zone.

METHOD OF INHIBITING HISTAMINE ACTIVITY WITH GUANIDINE COMPOUNDS

A method of inhibiting histamine activity in particular inhibiting H-2 histamine receptors, by administering heterocyclicalkylguanidines.